Information
-
Trademark
-
90524586
-
International Classifications
-
Filing Date
February 11, 2021
3 years ago
-
Transaction Date
June 01, 2024
7 months ago
-
Status Date
June 01, 2024
7 months ago
-
Location Date
February 21, 2024
11 months ago
-
Status Code
602
-
Current Location
TMEG LAW OFFICE 107 - EXAMINING ATTORNEY ASSIGNED
Employee Name
ALTREE, NICHOLAS
-
Attorney Docket Number
B14622000200
Attorney Name
Christina M. Licursi
Law Office Assigned Location Code
L70
-
Owners
Mark Drawing Code
4
Mark Identification
BG
Case File Statements
- GS0441: Genetic testing for medical purposes, specifically, genomic, epigenomic, proteomic, transcriptomic, and molecular medical testing for cancer and other diagnostic or treatment purposes; providing medical information, namely, providing collected and analyzed medical information in the field of genetics, epigenetics, and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; providing medical information, specifically, providing collected and analyzed medical information in the field of genomics, epigenomics, proteomics, transcriptomics for diagnostic and treatment purposes; providing medical data and information to healthcare professionals; providing online computer databases of genomic sequences for health care and medical purposes, namely, for tracking, matching, searching, testing, aggregating, researching, evaluating health status, and diagnosing diseases and gene mutations; providing an online Internet website portal featuring medical information, namely, medical, genetic, epigenetic, genomic, proteomic, and transcriptomic information and data in the field of cancer for diagnostic and treatment purposes; providing an online Internet website portal featuring medical information, namely, medical, genetic, epigenetic, genomic, proteomic, and transcriptomic information and data for scientific, laboratory, and medical research and development purposes
- GS0421: Providing online, non-downloadable software for genetic and epigenetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing online computer databases featuring scientific research information in the field of genomic sequences for use in scientific research, namely, for tracking, matching, searching, testing, aggregating, researching, and evaluating health status, and diagnosing diseases and gene mutations; software as a service (SAAS) services featuring software for patient treatment protocols and for recommending treatments to patients; providing an online internet website portal featuring medical, genetic, epigenetic, genomic, epigenomic, proteomic, and transcriptomic research information and data in the field of cancer for diagnostic and treatment purposes; providing an online internet website portal featuring medical, genetic, epigenetic, genomic, epigenomic, proteomic, and transcriptomic research information and data for scientific, laboratory, and medical research and development purposes; medical research services; biomedical research services; structural and functional analysis of genomes; scientific research in the field of genomics and epigenomics; medical laboratory services being medical research, in the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disorders; providing temporary use of online, non-downloadable software used for the sequencing and analyses of genomic, epigenomic, proteomic, and transcriptomic data; providing temporary use of online, non-downloadable software used to integrate and create data models; software as a service (SAAS) services featuring software for analyzing and visualizing genomic, epigenomic, proteomic, and transcriptomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software as a service (SAAS) services featuring software for data management, for electronic storage of data in the field of clinical trials and electronic health records; providing online, non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, epigenetics, genomics, proteomics, transcriptomics, and biochemistry; providing online, nondownloadable software for use in clinical trial data management and for management of electronic health records; providing online, non-downloadable software for displaying, recording, and analyzing medical data and medical images
Case File Event Statements
-
5/15/2021 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
2/15/2021 - 3 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
10/15/2021 - 3 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
9/8/2021 - 3 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
10/15/2021 - 3 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
10/15/2021 - 3 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
4/14/2022 - 2 years ago
12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Type: GNS3
-
4/13/2022 - 2 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
4/13/2022 - 2 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
4/13/2022 - 2 years ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
4/14/2022 - 2 years ago
10 - SUSPENSION LETTER WRITTEN
Type: CNSL
-
4/14/2022 - 2 years ago
11 - LETTER OF SUSPENSION E-MAILED
Type: GNSL
-
10/14/2022 - 2 years ago
13 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Type: RCSC
-
4/13/2023 - a year ago
14 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Type: RCSC
-
12/22/2023 - a year ago
15 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Type: RCCK
-
2/21/2024 - 11 months ago
16 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
2/21/2024 - 11 months ago
17 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
2/21/2024 - 11 months ago
18 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
6/1/2024 - 7 months ago
20 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Type: MAB2
-
6/1/2024 - 7 months ago
19 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Type: ABN2